Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...

Issued on behalf of Oncolytics Biotech Inc.USANewsGroup.com News CommentaryVANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- The precision oncology market ...

Shareholders should contact the firm as there may be limited time to enforce your rights. NEW YORK, Dec. 23, 2025 /PRNewswire ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

"In light of the Company’s inability to presently predict the duration of the stop ship, the Company believes that it will be ...

The company’s GYN Surgical division posted revenues of $679.8 million in fiscal 2025, a 6% increase over fiscal 2024. Over ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics ...

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. | Hologic put forward another study that bolsters the use ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

For capital markets lawyers, 2025 was supposed to be a year of pipeline deals, AI-driven demand and a new presidential ...